The purpose of this activity is to improve the response to HIV to ensure sustained epidemic control in targeted geographic areas

This $2,777,976 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to improve the response to HIV and ensure sustained epidemic control in targeted areas of the Democratic Republic of Congo (DRC). The primary awardee, Family Health International (FHI 360), will implement activities to decrease new HIV infections and reduce HIV-associated morbidity and mortality in the Haut-Katanga province. This includes addressing factors that enable the uptake of HIV services at the provincial level to contribute to the global goal of ending the HIV epidemic as a public health threat by 2030.

The award involves several sub-grantees, including Sanru, Divas Haut-Katanga, RNOAC, AFEMDCO, CRISEM, and Maison Faradja, who will deliver HIV prevention, care, and treatment services to key and vulnerable populations in the DRC. Activities focus on strengthening healthcare infrastructure, improving patient outcomes, and developing robust supply chain systems for medical services and supplies in the target regions.

Activities will contribute to the reduction of DRC's HIV burden through decreasing new infections and HIV-associated morbidity and mortality in haut-katanga. Implementers will address the condition that enable the uptake of HIV services at the provincial levels to increase the DRC's contribution to the worldwide GOA; of ending the HIV epidemic as a public threat by 2030.